PTC
PTC
PTC
PTC NASDAQ
A report from seekingalpha.com titled 'PTC Inc.: The Market Is Pricing In Stagnation At 16x Earnings' draws attention to the company's current valuation. Fundamental metrics show PTC Inc. trading at a PE ratio of approximately 12.61, supported by a trailing twelve-month EPS of 10.67183480558438. The firm also presents a market capitalization of $15,114,814,844, alongside full-year revenue of $2,739,226,000 and a free cash flow yield of 6.189185971876798%.
Based on seekingalpha.comPTC Inc.: The Market Is Pricing In Stagnation At 16x Earnings
Amundi Has $107.65 Million Stock Position in PTC Inc. $PTC
PTC Inc. (PTC) Presents at Citi's 2026 Global TMT Conference Transcript
Hsbc Holdings PLC Purchases 231,563 Shares of PTC Inc. $PTC
PTC Inc. (PTC) Up 16.6% Since Last Earnings Report: Can It Continue?
PTC Therapeutics to Participate in Upcoming Investor Conferences
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Tape shows delayed public market data. Not investment advice.